Status:
RECRUITING
Partnering to Enhance Emerging Adults' Response to Programs
Lead Sponsor:
UConn Health
Collaborating Sponsors:
University of Texas
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Conditions:
Alcohol Use, Unspecified
Eligibility:
All Genders
18-19 years
Phase:
NA
Brief Summary
The goal of this clinical trial (CT) is to learn more about emerging adults' and their peers. Here, we will see how co-participating with a peer in health program might impact brain and behavior chang...
Eligibility Criteria
Inclusion
- within the specified age range
- agree to be contacted for the 3, 6, and 12 month follow ups
- provide fully informed consent
Exclusion
- left-handed
- evidence of brain injury/illness and/or neurological, neurodevelopmental disorder including psychosis and related medications (e.g., antipsychotics; neuroleptics)
- loss of consciousness ≥ 2 minutes
- other fMRI contraindications (e.g., unremovable metal on/in body, pregnant)
Key Trial Info
Start Date :
October 10 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2028
Estimated Enrollment :
248 Patients enrolled
Trial Details
Trial ID
NCT06115252
Start Date
October 10 2025
End Date
March 31 2028
Last Update
November 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas Dallas
Dallas, Texas, United States, 75235